MedPath

PROPOLUXE NUTRACEUTICAL PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

TGA:16

Drug Approvals

Propoluxe Menn+ (475834)

Product Name
Propoluxe Menn+
Approval Date
Jan 15, 2025
TGA

COLOSTRUM (475856)

Product Name
COLOSTRUM
Approval Date
Jan 15, 2025
TGA

Propoluxe EMM+ (475855)

Product Name
Propoluxe EMM+
Approval Date
Jan 15, 2025
TGA

Shark Cartilage 800 (467409)

Product Name
Shark Cartilage 800
Approval Date
Nov 6, 2024
TGA

Rosehip Extract 1500 mg Complex (467413)

Product Name
Rosehip Extract 1500 mg Complex
Approval Date
Nov 6, 2024
TGA

Ultra Royal Jelly (467411)

Product Name
Ultra Royal Jelly
Approval Date
Nov 6, 2024
TGA

Liver Tonic Active 33000 (467410)

Product Name
Liver Tonic Active 33000
Approval Date
Nov 6, 2024
TGA

Cranberry 65000 (467412)

Product Name
Cranberry 65000
Approval Date
Nov 6, 2024
TGA

Trametes versicolor LIVER (402096)

Product Name
Trametes versicolor LIVER
Approval Date
Jan 11, 2023
TGA

Trametes versicolor IMMUNITY (400169)

Product Name
Trametes versicolor IMMUNITY
Approval Date
Nov 25, 2022
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.